Post Job Free
Sign in

Manager Test

Location:
San Diego, CA
Posted:
October 10, 2013

Contact this candidate

Resume:

Daniel J Kim

651-***-****

***** ******** ** *********@***.***

San Diego, CA 92127

Professional Profile A scientist with expertise in bioassay development with neuroscience background.

Expertise in in-vitro cell based assay development

Expert in immunoassay development

Good with instrumentation and experienced with different detection

methods

Expert in primary cell culture and cancer cell line culture

Expert in imaging analysis using fluorescent dyes

Professional Biossay Development

Accomplishments Introduced multiple primary neuron based bioassay to test and release

numerous recombinant proteins related to neuroscience.

Developed new bioassays and improved existing bioassays for testing

angiogenesis related proteins and antibodies including VEGF family

and Angiopoietin family.

Trained and guided 4 research associates in multidisciplinary projects

to develop bioassays and immunoassays.

The Group under my supervision developed over 100 cell based assays

and immunoassays to test and release over 300 recombinant proteins

related to neuroscience, angiogenesis, adhesion molecules,

developmental biology, and immunology.

Neuroscience

Showed cannabinoids can inhibit new synapse formation in

hippocampal culture system using imaging analysis.

Showed cannabinoids can inhibit neurotransmitter release in

hippocampal culture system using imaging analysis.

Showed synchronized calcium oscillation in hippocampal culture

system using imaging analysis.

Work History September 2007 – August 2013

Manager/Scientist, R&D Systems, Minneapolis, MN

December 2000 – August 2007

Scientist, R&D Systems, Minneapolis, MN

October 1991 – September 1993

Medical Technologist, MedTox Lab, Minneapolis, MN

Education Ph.D. in Pharmacology

U of MN

Minneapolis, MN

September 30, 2000

B.S. in Medical Technology

U of MN, 1991

B.A. in Physics

U of MN, 1989

Partial list of assays Neuronal assays:

Cortical neuron survival assay to test Midkine and Pleotrophin.

developed

DRG neurite outgrowth inhibition assay to test Nogo-A, OMgp and MAG.

Cortical neuron and hippocampal neuron neurite outgrowth assay to neuronal adhesion

molecules and synaptic adhesion molecules .

Substantia nigra dopaminergic neuron survival assay to test GDNF.

Cell-based assays:

HMVEC proliferation assay to test VEGF-C, VEGF-D, and neutralizing antibodies.

EJG cell proliferation assay to test EG-VEGF.

T98G cell proliferation assay to test GAS6.

SHSY5Y cell proliferation assay to test Artemin and GDNF,

TT cell proliferation assay to test Persephin

HUVEC apoptosis assay to test Angiopoietin-1.

Functional ELISA to test:

VEGF-A, -B, -C, -D, and neutralizing antibodies.

VEGF-R1, VEGF-R2, VEGF-R3, and neutralizing antibodies.

Angiopoietin-2, -3, -4, and neutralizing antibodies.

RGM-A, -B, -C, ROBO receptors, and Integrin family.

Other assays:

Calcium flux assay to test Wnt5A.

pSTAT3 Western to test IL-22.

Instruments:

Octet (ForteBio's), NOVOstar (BMG labtech), Gemini (Molecular Devices),

FLx800 (BioTek)

Publications Cannabinoids inhibit the formation of new synapses between hippocampal

neurons in culture. Kim DJ, Thayer SA. Journal of Neuroscience. 2001 May

15;21(10):RC146.

Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from

identified synaptic sites in rat hippocampal cultures. Kim DJ, Thayer SA. Brain

Research. 2000 Jan 10;852(2):398-405.

Neurotoxicity mediated by aberrant patterns of synaptic activity between rat

hippocampal neurons in culture. McLeod JR Jr, Shen M, Kim DJ, Thayer SA.

Journal of Neurophysiology. 1998 Nov;80(5):2688-98.



Contact this candidate